Table 1 Descriptive statistics of the assessments in the study

From: Distribution and impact on quality of life of the pain modalities assessed by the King’s Parkinson’s disease pain scale

 

Patients

Controls

 

Mean

SD

Med.

Range

Mean

SD

Med.

Range

SCOPA-motor scale

17.38

10.28

15

1–65

–

–

–

–

NMSS

60.71

44.31

48

0–235

–

–

–

–

CISI-PD

6.54

3.93

6

0–19

–

–

–

–

HADS-anxiety

6.17

4.56

5

0–20

5.92

4.32

5

0–20

HADS-depression

5.44

3.96

5

0–18

4.69

3.81

4

0–18

EQ-5D-3L

0.52

0.28

0.62

−0.43–1

0.60

0.29

0.66

−0.43–1

PDQ-8

27.84

20.28

25

0–93.75

–

–

–

–

PDSS-2

18.25

11.20

16.50

0–51

–

–

–

–

VAS pain

32.92

23.84

27.67

0–100

–

–

–

–

King’s PD pain scale

 1. Musculoskeletal pain

6.02

4.07

6

0–12

3.66

3.69

3

0–12

 2. Chronic pain

3.37

5.53

0

0–24

1.37

3.23

0

0–18

 3. Fluctuation-related pain

5.27

8.26

0

0–36

0.63

2.30

0

0–14

 4. Nocturnal pain

4.91

5.87

3

0–24

1.49

3.36

0

0–15

 5. Oro-facial pain

0.97

3.00

0

0–22

0.24

1.42

0

0–12

 6. Discolouration, OS

2.29

4.49

0

0–24

0.87

2.66

0

0–15

 7. Radicular pain

2.36

3.53

0

0–12

1.07

2.49

0

0–12

KPPS Total score

25.19

22.14

17

0–102

9.34

12.58

4

0–63

  1. SD standard deviation, Med median, SCOPA scales for outcomes in Parkinson’s disease, NMSS non-motor symptoms scale, CISI-PD clinical impression of severity index-Parkinson’s disease, HADS hospital anxiety and depression scale, EQ-5D-3L EuroQoL-5 dimensions-3 levels, PDQ-8 Parkinson’s disease questionnaire-8 items, PDSS-2 Parkinson’s disease sleep scale-version 2, VAS visual analog scale. Discolouration, OS discolouration; edema/Swelling, KPPS King’s Parkinson’s disease pain scale
Back to article page